Sbi Securities Co., Ltd. Actinium Pharmaceuticals, Inc. Transaction History
Sbi Securities Co., Ltd.
- $3.48 Trillion
- Q2 2025
A detailed history of Sbi Securities Co., Ltd. transactions in Actinium Pharmaceuticals, Inc. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 542 shares of ATNM stock, worth $818. This represents 0.0% of its overall portfolio holdings.
Number of Shares
542
Previous 542
-0.0%
Holding current value
$818
Previous $873,000
13.06%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ATNM
# of Institutions
60Shares Held
6.98MCall Options Held
51.9KPut Options Held
6.2K-
Black Rock Inc. New York, NY1.88MShares$2.83 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.37MShares$2.07 Million0.0% of portfolio
-
State Street Corp Boston, MA645KShares$974,2740.0% of portfolio
-
Acadian Asset Management LLC Boston, MA492KShares$742,8330.0% of portfolio
-
Ubs Group Ag396KShares$598,1650.0% of portfolio
About Actinium Pharmaceuticals, Inc.
- Ticker ATNM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,184,700
- Market Cap $38M
- Description
- Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly re...